Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids

Prostaglandins Leukot Essent Fatty Acids. 2021 Aug:171:102315. doi: 10.1016/j.plefa.2021.102315. Epub 2021 Jul 3.

Abstract

The additive effects of prostaglandin (PG)-EP2 agonists on a PG-FP agonist toward adipogenesis in two- or three-dimension (2D or 3D) cultures of 3T3-L1 cells was examined by lipid staining, the mRNA expression of adipogenesis related genes, and extracellular matrixes (ECMs) including collagen molecules (Col) -1, -4 and -6, and fibronectin (Fn), and the sizes and physical properties of 3D sphenoids, as measured by a micro-squeezer. The results indicate that adipogenesis induced 1) an enlargement in the sizes of 3D sphenoids, 2) a substantial enhancement in lipid staining, the expression of the PParγ, Ap2 and Leptin genes, and 3) a significant decrease in the stiffness of the 3D sphenoids. These effects were inhibited by bimatoprost acid (BIM-A), but 4) adipogenesis induced significant down-regulation of Col1 and Fn, and the significant up-regulation of the Col4 and Col6 genes were unchanged by BIM-A. On the addition of an EP2 agonist, such as omidenepag (OMD) or butaprost (Buta), to BIM-A, 1) the sizes of the 3D sphenoids were further decreased, 2) lipid staining was decreased (2D; OMD, 3D; Buta) 3) the stiffness of the 3D sphenoids was increased by Buta, 4) the expression of PParγ was up-regulated (2D; Buta) or unchanged (3D), the expression of Ap2 was down-regulated (2D; OMD) or up-regulated (3D; Buta), and the expression of Leptin was increased (2D), 5) the expression of all four (OMD) or all except Col4 (buta) in 2D, and Col1and Col4 (OMD) in 3D were up-regulated. These collective findings indicate that the addition of an EP2 agonist, OMD or Buta significantly modulated the BIM-A induced suppression of adipogenesis as well as physical properties of 2D and 3D cultured 3T3-L1 cells in different manners.

Keywords: 3T3-L1; EP2 agonist; FPagonist; Three-dimension culture.

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis / drug effects*
  • Adipogenesis / genetics
  • Alprostadil / analogs & derivatives*
  • Alprostadil / pharmacology
  • Animals
  • Bimatoprost / pharmacology*
  • Cell Culture Techniques, Three Dimensional
  • Collagen Type I / drug effects
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Collagen Type IV / drug effects
  • Collagen Type IV / genetics
  • Collagen Type IV / metabolism
  • Collagen Type VI / drug effects
  • Collagen Type VI / genetics
  • Collagen Type VI / metabolism
  • Drug Synergism
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / metabolism
  • Fatty Acid-Binding Proteins / drug effects*
  • Fatty Acid-Binding Proteins / genetics
  • Fatty Acid-Binding Proteins / metabolism
  • Fibronectins / drug effects
  • Fibronectins / genetics
  • Fibronectins / metabolism
  • Glycine / analogs & derivatives*
  • Glycine / pharmacology
  • Leptin / genetics*
  • Leptin / metabolism
  • Mice
  • PPAR gamma / drug effects*
  • PPAR gamma / genetics
  • PPAR gamma / metabolism
  • Pyrazoles / pharmacology*
  • Pyridines / pharmacology*
  • Receptors, Prostaglandin / agonists*
  • Receptors, Prostaglandin E, EP2 Subtype / agonists*
  • Spheroids, Cellular / drug effects
  • Spheroids, Cellular / metabolism

Substances

  • Collagen Type I
  • Collagen Type IV
  • Collagen Type VI
  • Fabp4 protein, mouse
  • Fatty Acid-Binding Proteins
  • Fibronectins
  • Leptin
  • PPAR gamma
  • Pyrazoles
  • Pyridines
  • Receptors, Prostaglandin
  • Receptors, Prostaglandin E, EP2 Subtype
  • prostaglandin F2alpha receptor
  • Alprostadil
  • omidenepag isopropyl
  • butaprost
  • Bimatoprost
  • Glycine